• Sabrina Bakeera-Kitaka, Caring for Young People with HIV in Uganda. Family
Health International Report, January 2009,Volume 3, Issue 1
• Ocama P, Namboze S, Opio CK, Shiels MS, Wabinga HR, Kirk GD. Trends in the
incidence of liver cancer in Central Uganda, 1960-1980, 1991-2005. Br J Cancer 2009: 1-4
• Ocama P, Kagimu MM, Opio KC, Odida M, Wabinga H, Colebunders B,
Colebunders R. Prevalence of cancer of the esophagus in patients attending the endoscopy Unit, Mulago Hospital. African Health Sciences 2008;8:80-84
• Sabrina Bakeera-Kitaka, Update on New Guidelines for Paediatric Antiretroviral
therapy ATIC News,Vol 4,Issue 4 Dec 2008
• Kiragga A., Ocama P., Reynolds S. R., Kambugu A, Ojiambo H, Castelnuovo B.
Validation of a portable hand-held analyzer for determination of blood lactate in patients on antiretroviral therapy in Uganda. J. Acquir. Immune Defic Syndr. Vol 49, Number 5, December 15, 2008
• Nakanjako D, Kiragga A, Ibrahim F, Castelnuovo B, Kamya MR, Easterbrook PJ.
• Ocama P, Kagimu M, Odida M, Wabinga H, Opio C.K, Colebunders B, Ierssel S,
Colebunders R. Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda. African Health Sciences, Vol 8 No 2 2008
• Byakika-Kibwika P, Lamorde M, Kalemeera F, D'Avolio A, Mauro S, Di Perri G,
Ryan M, Mayanja-Kizza H, Khoo S, Back D, Boffito M, Merry C. Steady-state pharmacokinetic comparison of generic and branded formulations of nevirapine, stavudine (d4T), and lamivudine (3TC) in HIV-infected Ugandan adults. J Antimicrob Chemother. 2008 Nov; 62(5):1113-7.
• Castelnuovo B, Nanyonjo A, Kamya M, Ocama P. Is it safe to switch from stavudine
to zidovudine after developing symptomatic hyperlactatemia? African Health Sciences 2008; 8(2): 133-134
• Kekitiinwa A, Lee K. J, Walker A.S. Maganda A. Doerholt K, Bakeera-Kitaka S,
Asiimwe A, Judd A. Musoke P, Gibb D. Differences in Factors Associated With Initial Growth, CD4, and Viral Load Responses to ART in HIV-Infected Children in
Kampala, Uganda, and the United Kingdom/Ireland. J. Acquir. Immune Defic Syndr. 49(4):384-392
• Bakeera-Kitaka S, Birnbaum J, Doerholt K, Donna C. Futterman, Dick B A health
provider’s perspective on strengthening care, support, treatment and prevention for young people living with HIV/AIDS. WHO/FCH/CAH/08.02
• Bakeera-Kitaka S. Update on early initiation of c-ART in children less than one
year’ ATIC newsletter Vol 4, Issue 3 September 2008
• Ocama P. Treatment of hepatitis B virus infection in patients co-infected with HIV in
Uganda, ATIC newsletter Vol 4, Issue 3 September 2008
• Ocama P. Hepatitis B. Uganda Society for Health Scientists Newsletter 2008: 9:7 • Castelnuovo B, Ocama P, Songa PM, Kambugu A. Reply to Griensven on lactic
• Ocama P, Katwere M, Piloya T, Feld J, Opio K.C, Kambugu A, Katabira E, Thomas
D, Colebunders R, Ronald A. The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda African Health Sciences 2008; 8(1): 8-13
• Lamorde M, Byakika – Kibwika, Merry C. Antiretroviral therapy in developing
countries: Pharmacologic considerations. Current Opinion in HIV and AIDS 2008, 3:252–257
• Bakeera - Kitaka S, Nabukeera - Birungi N, Noestlinger C, Kekitiinwa A,
Colebunders B. Assessing Sexual Risk Reduction Needs of Adolescents Living with HIV in a Clinical Care Setting. AIDS Care, 20:4, 426 — 433
• Bakeera-Kitaka S, McKellar M, Snider C, Kekitiinwa A, Piloya T, Musoke P,
Ronald A, Colebunders R. Antiretroviral therapy for HIV-1 Infected Adolescents in Uganda: Assessing the Impact on Growth and Sexual Maturation. JPID Volume 3, Number 2, Year 2008
• Mwebaze Songa P, Castelnuovo B, Birabwa Mugasha E, Ocama P, Kambugu A.
Symptomatic hyperlactatemia associated nucleoside analogue reverse transcriptase inhibitor use in HIV-infected patients: A report of 24 cases in a resource limited setting. Clin Infect Dis 2007, 45:514-517
• Castelnuovo B, Ocama P, Kambugu A, Songa M. P. Symptomatic hyperlactatemia
associated nucleoside analogue reverse transcriptase inhibitor use in HIV-infected patients: Response to Griensven et al. Clin Infect Dis 2007
• Nakanjako D, Kamya M, Kyabayinze D, Mayanja-Kizza H, Freers J, Whalen C,
Katabira E. Acceptance of Routine Testing for HIV among Adult Patients at the Medical Emergency Unit at a National Referral Hospital in Kampala, Uganda. AIDS Behav. 2007 Sept; 11(5):753-8
• Nakanjako D, Kyabayinze D.J, Mayanja-Kizza H, Katabira E, Kamya M.R.
Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at
an urban hospital in Uganda African Health Sciences. 2007 Vol 7 No 3 September 2007
• Bakeera-Kitaka S, McKellar M, Snider C, Kekitiinwa A, Piloya T, Musoke P,
Ronald A, Colebunders R. Antiretroviral therapy for HIV-1 Infected Adolescents in Uganda: Assessing the Impact on Growth and Sexual Maturation. PIDJ 2007
Computing & Software proactive spam controls by Nithen Naidoo, Deloitte Security and Privacy Services The internet has introduced the world to a façade of electronic freedom. This “freedom” is often exploited by malicious or opportunistic members of the internet community. A prime example of such an injustice is spam. There are many definitions of spam. Mail abuse prevention syste
Theresienkrankenhaus und St. Hedwig-Klinik GmbH Akademisches Lehrkrankenhaus der Universität Heidelberg \Pta-Pka\Tabellen\Sonde\Peroralia-Applikation Sondengängigkeit von Peroralia Hinweis: Kann ein Medikament nicht über die Sonde gegeben werden, bitte Arzt informieren und neue Verordnung einholen. Für Rückfragen steht auch die Apotheke unter Tel.: 4223 oder 4573 oder 4574 zur Verf
SEWANKAMBO SCHOLAR PUBLICATIONS